Timing of intravenous immunoglobulin treatment and outcome in <scp>Guillain</scp>–<scp>Barré</scp> syndrome: Is time nerve?
Our study highlights the timing of IVIg as a modifiable prognostic factor in GBS. The earlier IVIg is initiated, the better the outcomes, with the ideal time window being within the first 2 weeks. These findings underscore the importance of prompt diagnosis and early intervention to optimize recovery in GBS patients.
Authors
- Jung‐Joon Sung (ORCID: https://orcid.org/0000-0001-7525-5313)
- Yusuf A. Rajabally (ORCID: https://orcid.org/0000-0002-7170-8343)
- Yoon‐Ho Hong (ORCID: https://orcid.org/0000-0002-3325-6358)
- Young Gi Min (ORCID: https://orcid.org/0000-0002-8091-7585)
Institutions
- Seoul National University (KR)
- Aston University (GB)
- Seoul Metropolitan Government (KR)
- Seoul National University Hospital (KR)
- SNUH SMG-SNU Boramae Medical Center (KR)
Publication Details
- Journal
- Muscle & Nerve
- Published
- 2024-10-03
- DOI
- https://doi.org/10.1002/mus.28271
- Citations
- 7
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.58
Funders
- National Research Foundation
- National Research Foundation of Korea